{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:05:51Z","timestamp":1791947151349,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007197","name":"US Public Health Service Commissioned Corps","doi-asserted-by":"publisher","award":["HHSN-271-2013-00030"],"award-info":[{"award-number":["HHSN-271-2013-00030"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001819","name":"International Rett Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.neuroscience.2026.01.040","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:06:38Z","timestamp":1769792798000},"page":"9-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Profiling metabotropic glutamate receptor 7 expression in Rett syndrome: consequences for pharmacotherapy"],"prefix":"10.1016","volume":"598","author":[{"given":"Sheryl Anne D.","family":"Vermudez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geanne A.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco G.","family":"Gogliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Niswender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2026.01.040_b0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12887-024-04526-3","article-title":"Safety and efficacy of trofinetide in Rett syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Abbas","year":"2024","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020954","article-title":"Paving therapeutic avenues for FOXG1 syndrome: untangling genotypes and phenotypes from a molecular perspective","volume":"23","author":"Akol","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0020","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1038\/s41598-023-35516-7","article-title":"Respiration organizes gamma synchrony in the prefronto-thalamic network","volume":"13","author":"Basha","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0025","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1212\/01.wnl.0000304752.50773.ec","article-title":"Investigating genotype-phenotype relationships in Rett syndrome using an international data set","volume":"70","author":"Bebbington","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0030","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/hmg\/ddp181","article-title":"Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus","volume":"18","author":"Ben-Shachar","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0035","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nn.2142","article-title":"PICK1 uncoupling from mGluR7a causes absence-like seizures","volume":"11","author":"Bertaso","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0040","unstructured":"Brockmann, K., Staudt, M., 1993. FOXG1 Syndrome, in GeneReviews((R)) (Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. eds), Seattle (WA)."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0045","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/hmg\/ddv496","article-title":"The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome","volume":"25","author":"Brown","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0050","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1100\/tsw.2002.146","article-title":"Altered short-term synaptic plasticity in mice lacking the metabotropic glutamate receptor mGlu7","volume":"2","author":"Bushell","year":"2002","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12920-016-0208-3","article-title":"Exome sequencing in mostly consanguineous Arab families with neurologic disease provides a high potential molecular diagnosis rate","volume":"9","author":"Charng","year":"2016","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0060","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2147\/NDT.S371483","article-title":"Rett syndrome and MECP2 duplication syndrome: disorders of MeCP2 dosage","volume":"18","author":"Collins","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jmedgenet-2013-102113","article-title":"Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome","volume":"51","author":"Cuddapah","year":"2014","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0070","first-page":"2095","article-title":"Rett and Rett-related disorders: common mechanisms for shared symptoms?","volume":"248","author":"D'Mello","year":"2023","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0075","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/cercor\/12.9.961","article-title":"Enrichment of mGluR7a in the presynaptic active zones of GABAergic and non-GABAergic terminals on interneurons in the rat somatosensory cortex","volume":"12","author":"Dalezios","year":"2002","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1096\/fj.10-163147","article-title":"A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors","volume":"25","author":"Doumazane","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s11689-024-09575-4","article-title":"Associations between genotype, phenotype and behaviours measured by the Rett syndrome behaviour questionnaire in Rett syndrome","volume":"16","author":"Downs","year":"2024","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0090","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/gbb.12084","article-title":"Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior","volume":"12","author":"Fentress","year":"2013","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0095","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143324","article-title":"A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypes","volume":"6","author":"Fisher","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0100","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12654","article-title":"Phenotypic profiling of mGlu7 knockout mice reveals new implications for neurodevelopmental disorders","volume":"19","author":"Fisher","year":"2020","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0105","article-title":"Metabotropic glutamate receptor 7: a new therapeutic target in neurodevelopmental disorders","volume":"11","author":"Fisher","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0110","doi-asserted-by":"crossref","first-page":"14015","DOI":"10.1007\/s12035-025-05183-y","article-title":"Overexpression of mGlu(7B) in mice: implications for neurodevelopmental disorders","volume":"62","author":"Freitas","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1284035","article-title":"Trofinetide-a new chapter in rett syndrome's treatment","volume":"14","author":"Furqan","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0120","doi-asserted-by":"crossref","first-page":"10975","DOI":"10.1074\/jbc.M113.542654","article-title":"Blocking metabotropic glutamate receptor subtype 7 (mGlu7) via the Venus flytrap domain (VFTD) inhibits amygdala plasticity, stress, and anxiety-related behavior","volume":"289","author":"Gee","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2019.04.016","article-title":"The mGlu7 receptor provides protective effects against epileptogenesis and epileptic seizures","volume":"129","author":"Girard","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/jpet.117.246991","article-title":"Total RNA sequencing of Rett syndrome autopsy samples identifies the M4 muscarinic receptor as a novel therapeutic target","volume":"365","author":"Gogliotti","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai7459","article-title":"mGlu7 potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome","volume":"9","author":"Gogliotti","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0140","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw074","article-title":"mGlu5 positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndrome","author":"Gogliotti","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41572-024-00568-0","article-title":"Rett syndrome","volume":"10","author":"Gold","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0150","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1038\/s41467-019-13407-8","article-title":"Conformational pathway provides unique sensitivity to a synaptic mGluR","volume":"10","author":"Habrian","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0155","first-page":"1142","article-title":"Trofinetide receives FDA approval as first drug for Rett syndrome","volume":"329","author":"Harris","year":"2023","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0160","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0277-17.2017","article-title":"Activation of the medial prefrontal cortex reverses cognitive and respiratory symptoms in a mouse model of Rett syndrome","volume":"4","author":"Howell","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0165","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/cn500153z","article-title":"Identification of positive allosteric modulators VU0155094 (ML397) and VU0422288 (ML396) reveals new insights into the biology of metabotropic glutamate receptor 7","volume":"5","author":"Jalan-Sakrikar","year":"2014","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0170","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/j.celrep.2016.08.004","article-title":"Tcf4 regulates synaptic plasticity, DNA methylation, and memory function","volume":"16","author":"Kennedy","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0175","article-title":"Development of trofinetide for the treatment of Rett syndrome: from bench to bedside","volume":"14","author":"Kennedy","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0180","doi-asserted-by":"crossref","first-page":"7600","DOI":"10.1523\/JNEUROSCI.4543-14.2015","article-title":"Activation of metabotropic glutamate receptor 7 is required for induction of long-term potentiation at SC-CA1 synapses in the hippocampus","volume":"35","author":"Klar","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0185","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s42003-023-04468-z","article-title":"Kinetic fingerprinting of metabotropic glutamate receptors","volume":"6","author":"Kukaj","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107891","article-title":"Defining the homo- and heterodimerization propensities of metabotropic glutamate receptors","volume":"31","author":"Lee","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0195","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1136\/jmg.40.5.e52","article-title":"Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations?","volume":"40","author":"Leonard","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0200","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1474-4422(22)00035-7","article-title":"CDKL5 deficiency disorder: clinical features, diagnosis, and management","volume":"21","author":"Leonard","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0205","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuron.2016.08.036","article-title":"Mechanism of assembly and cooperativity of homomeric and heteromeric metabotropic glutamate receptors","volume":"92","author":"Levitz","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102458","article-title":"Differential activity of mGlu(7) allosteric modulators provides evidence for mGlu(7\/8) heterodimers at hippocampal Schaffer collateral-CA1 synapses","volume":"298","author":"Lin","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0215","doi-asserted-by":"crossref","first-page":"8552","DOI":"10.1038\/s41467-024-52822-4","article-title":"Elucidating the molecular logic of a metabotropic glutamate receptor heterodimer","volume":"15","author":"Lin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0220","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26985","article-title":"Allosteric control of an asymmetric transduction in a G protein-coupled receptor heterodimer","volume":"6","author":"Liu","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14020120","article-title":"Rett syndrome and the role of MECP2: signaling to clinical trials","volume":"14","author":"Lopes","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0230","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/acn3.51003","article-title":"Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy","volume":"7","author":"Marafi","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/jmg.2009.067884","article-title":"Novel FOXG1 mutations associated with the congenital variant of Rett syndrome","volume":"47","author":"Mencarelli","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0240","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.25233","article-title":"Pharmacological evidence for a metabotropic glutamate receptor heterodimer in neuronal cells","volume":"6","author":"Moreno Delgado","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0245","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","article-title":"Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome","volume":"70","author":"Neul","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0250","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0255","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41591-023-02398-1","article-title":"Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study","volume":"29","author":"Neul","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pediatrneurol.2023.11.005","article-title":"Trofinetide treatment demonstrates a benefit over placebo for the ability to communicate in Rett syndrome","volume":"152","author":"Neul","year":"2024","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0265","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1172805","article-title":"Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives","volume":"17","author":"Palmieri","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0275","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10354-016-0491-9","article-title":"Progress in Rett syndrome: from discovery to clinical trials","volume":"166","author":"Percy","year":"2016","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0280","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s40263-024-01106-y","article-title":"Rett syndrome: the emerging landscape of treatment strategies","volume":"38","author":"Percy","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0285","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.braindev.2008.04.007","article-title":"Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant)","volume":"31","author":"Renieri","year":"2009","journal-title":"Brain Dev."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0290","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamapsychiatry.2016.3798","article-title":"Diagnostic yield and novel candidate genes by exome sequencing in 152 consanguineous families with neurodevelopmental disorders","volume":"74","author":"Reuter","year":"2017","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0295","doi-asserted-by":"crossref","first-page":"8734","DOI":"10.1523\/JNEUROSCI.21-22-08734.2001","article-title":"Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7","volume":"21","author":"Sansig","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0300","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/381523a0","article-title":"Target-cell-specific concentration of a metabotropic glutamate receptor in the presynaptic active zone","volume":"381","author":"Shigemoto","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0305","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-022-01254-3","article-title":"Clinical and preclinical evidence for M1 muscarinic acetylcholine receptor potentiation as a therapeutic approach for Rett syndrome","author":"Smith","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106859","article-title":"Potentiation of the M(1) muscarinic acetylcholine receptor normalizes neuronal activation patterns and improves apnea severity in Mecp2(+\/-) mice","volume":"208","author":"Smith","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0315","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1046\/j.1460-9568.2003.02697.x","article-title":"High level of mGluR7 in the presynaptic active zones of select populations of GABAergic terminals innervating interneurons in the rat hippocampus","volume":"17","author":"Somogyi","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0320","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1523\/JNEUROSCI.2108-20.2021","article-title":"Pathogenic GRM7 mutations associated with neurodevelopmental disorders impair axon outgrowth and presynaptic terminal development","volume":"41","author":"Song","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0325","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1038\/emm.2013.32","article-title":"Pitt-Hopkins Syndrome: intellectual disability due to loss of TCF4-regulated gene transcription","volume":"45","author":"Sweatt","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0330","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ejhg.2014.217","article-title":"Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications","volume":"23","author":"Szafranski","year":"2015","journal-title":"Eur. J. Hum. Genet.: EJHG"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0335","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fncir.2016.00031","article-title":"Phasic and tonic mGlu7 receptor activity modulates the thalamocortical network","volume":"10","author":"Tassin","year":"2016","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0340","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/humu.23542","article-title":"MECP2 variation in Rett syndrome-an overview of current coverage of genetic and phenotype data within existing databases","volume":"39","author":"Townend","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0345","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1261\/rna.080220.124","article-title":"Site-blocking antisense oligonucleotides as a mechanism to fine-tune MeCP2 expression","volume":"30","author":"Vanderplow","year":"2024","journal-title":"RNA"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0350","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ajmg.a.10053","article-title":"Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype","volume":"118A","author":"Weaving","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0355","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1038\/tp.2012.39","article-title":"TCF4 sequence variants and mRNA levels are associated with neurodevelopmental characteristics in psychotic disorders","volume":"2","author":"Wirgenes","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.01.040_b0360","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abd2319","article-title":"Input-specific regulation of glutamatergic synaptic transmission in the medial prefrontal cortex by mGlu2\/mGlu4 receptor heterodimers","volume":"14","author":"Xiang","year":"2021","journal-title":"Sci. Signal."},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2026.01.040_b0365","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1016\/S0387-7604(01)00378-3","article-title":"Mutation analysis of the methyl-CpG-binding protein 2 gene (MECP2) in Rett patients with preserved speech","volume":"23","author":"Yamashita","year":"2001","journal-title":"Brain Dev."},{"key":"10.1016\/j.neuroscience.2026.01.040_b0370","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1523\/JNEUROSCI.1129-13.2014","article-title":"Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS","volume":"34","author":"Yin","year":"2014","journal-title":"J. Neurosci."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226000771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226000771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:05:45Z","timestamp":1782216345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226000771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":74,"alternative-id":["S0306452226000771"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.01.040","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiling metabotropic glutamate receptor 7 expression in Rett syndrome: consequences for pharmacotherapy","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.01.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization (IBRO).","name":"copyright","label":"Copyright"}]}}